| Sanida Lukovic, MD | |
|
1400 Pelham Pkwy S Bldg 6, Bronx, NY 10461-1119 | |
| (347) 260-8962 | |
| Not Available |
| Full Name | Sanida Lukovic |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 1400 Pelham Pkwy S Bldg 6, Bronx, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013411818 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 316256 (New York) | Primary |
| Entity Name | Icahn School Of Medicine At Mount Sinai |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477899078 PECOS PAC ID: 2264691070 Enrollment ID: O20130717000798 |
News Archive
The success of blood stem cell transplants used to treat diseases such as leukemia, Hodgkin's lymphoma and aplastic anemia may soon become more predictable, thanks to a discovery made by researchers at the University of British Columbia.
NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced that it has closed $20 million in a Series D round of equity financing.
University of Warwick expertise is contributing to a world-first £1.5million study aiming to tackle one of the biggest public health threats we face – antibiotic resistance.
In the drug industry, clinical trials carry price tags that run well into the tens of millions of dollars. Managing such costs demands a sure hand, and trial sponsors go to great lengths to monitor and manage funds allocated to vendors.
In a breakthrough that could one day help individuals with cognitive impairment, researchers at Columbia University Irving Medical Center identified a specific receptor related to the neurotransmitter serotonin that could be targeted with drugs to boost memory.
› Verified 6 days ago
| Entity Name | Fpa Hospital Based |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629319413 PECOS PAC ID: 4789826694 Enrollment ID: O20130806000185 |
News Archive
The success of blood stem cell transplants used to treat diseases such as leukemia, Hodgkin's lymphoma and aplastic anemia may soon become more predictable, thanks to a discovery made by researchers at the University of British Columbia.
NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced that it has closed $20 million in a Series D round of equity financing.
University of Warwick expertise is contributing to a world-first £1.5million study aiming to tackle one of the biggest public health threats we face – antibiotic resistance.
In the drug industry, clinical trials carry price tags that run well into the tens of millions of dollars. Managing such costs demands a sure hand, and trial sponsors go to great lengths to monitor and manage funds allocated to vendors.
In a breakthrough that could one day help individuals with cognitive impairment, researchers at Columbia University Irving Medical Center identified a specific receptor related to the neurotransmitter serotonin that could be targeted with drugs to boost memory.
› Verified 6 days ago
| Entity Name | Icahn School Of Medicine At Mount Sinai |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124392238 PECOS PAC ID: 1850514258 Enrollment ID: O20140603000259 |
News Archive
The success of blood stem cell transplants used to treat diseases such as leukemia, Hodgkin's lymphoma and aplastic anemia may soon become more predictable, thanks to a discovery made by researchers at the University of British Columbia.
NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced that it has closed $20 million in a Series D round of equity financing.
University of Warwick expertise is contributing to a world-first £1.5million study aiming to tackle one of the biggest public health threats we face – antibiotic resistance.
In the drug industry, clinical trials carry price tags that run well into the tens of millions of dollars. Managing such costs demands a sure hand, and trial sponsors go to great lengths to monitor and manage funds allocated to vendors.
In a breakthrough that could one day help individuals with cognitive impairment, researchers at Columbia University Irving Medical Center identified a specific receptor related to the neurotransmitter serotonin that could be targeted with drugs to boost memory.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sanida Lukovic, MD 2510 30th Ave, Astoria, NY 11102-2448 Ph: () - | Sanida Lukovic, MD 1400 Pelham Pkwy S Bldg 6, Bronx, NY 10461-1119 Ph: (347) 260-8962 |
News Archive
The success of blood stem cell transplants used to treat diseases such as leukemia, Hodgkin's lymphoma and aplastic anemia may soon become more predictable, thanks to a discovery made by researchers at the University of British Columbia.
NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced that it has closed $20 million in a Series D round of equity financing.
University of Warwick expertise is contributing to a world-first £1.5million study aiming to tackle one of the biggest public health threats we face – antibiotic resistance.
In the drug industry, clinical trials carry price tags that run well into the tens of millions of dollars. Managing such costs demands a sure hand, and trial sponsors go to great lengths to monitor and manage funds allocated to vendors.
In a breakthrough that could one day help individuals with cognitive impairment, researchers at Columbia University Irving Medical Center identified a specific receptor related to the neurotransmitter serotonin that could be targeted with drugs to boost memory.
› Verified 6 days ago
Dr. Thomas Henry Parry, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 234 E 149th St, Bronx, NY 10451 Phone: 718-579-6010 | |
May Yee Helman, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1650 Grand Concourse, Bronx, NY 10457 Phone: 718-992-7669 | |
Dr. Angelica Rosa Angiulli, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1825 Eastchester Rd, Bronx, NY 10461 Phone: 718-904-2904 | |
Dr. Patrick Spencer Eiben, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1400 Pelham Pkwy S, Building 6//suite B125, Bronx, NY 10461 Phone: 718-918-5820 | |
Nai Li, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4422 3rd Ave, Bronx, NY 10457 Phone: 718-960-9000 | |
Vinay Saggar, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1400 Pelham Pkwy S Ste B125, Bronx, NY 10461 Phone: 718-918-5820 | |
Joshua Ronald Gravel, MD, MSC Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 234 E 149th St, Bronx, NY 10451 Phone: 239-233-1156 |